Case Study
Ryan Murray, PhD
Co-Founder & CSO
Ryan drives KiraGen Bio’s research strategy, pioneering next-generation CAR-T therapies for solid tumors.
KiraGen Bio, a fast-growing oncology biotech, faced a familiar challenge: evaluating new programs, competing for grants, and preparing for the clinic - all with a small team already stretched thin.
Their old approach relied on PubMed, ClinicalTrials.gov, and scraping conference abstracts. It was slow, fragmented, and often unreliable. They even tried leveraging ChatGPT, but too often it produced irrelevant or fabricated results.
With AcademicLabs, KiraGen replaced this patchwork with a single cockpit for scientific intelligence.
In just a quick dive, they could:
- Landscape a new indication from scratch, from biology, funding & experts all in one view.
- Map clinical hotspots and identify hidden KOLs critical to guiding their next steps.
- Spot why past grant submissions fell short and recalibrate for success.
- Rely on structured, trustworthy insights, not AI guesswork.
Read the full story on how AcademicLabs helps lean biotech teams move faster with confidence.
KiraGen Bio is pioneering next-generation AI-designed multiplex gene-edited CAR-T therapies to overcome tumor immunosuppression in brain cancer and other hard-to-treat tumors. Their transformer-based machine learning platform leverages high-throughput functional assays to predict and prioritize synergistic gene edits, enabling the design of CAR-T cells with improved persistence and efficacy against highly immunosuppressive tumors.
Ryan Murray is the Co-Founder and Chief Scientific Officer driving KiraGen Bio’s research strategy, pioneering next-generation CAR-T therapies for solid tumors.
KiraGen Bio, an early-stage oncology biotech, faced the common startup dilemma: how to evaluate new programs, compete for grants, and prepare for clinical development - all while fundraising and operating with a lean team. Their old workflow relied on weeks of PubMed searches, ClinicalTrials.gov digging, and scraping conference abstracts. It was slow, fragmented, and left gaps and opportunities.
As Co-Founder & CSO Ryan Murray puts it:
“Keeping up with everything is really challenging. We don’t have a dedicated team to inform everyone of current trends, new data or competitive intelligence, so we either sink weeks of our own time into it or accept blind spots.”
Through AcademicLabs’ Nucleate partnership, KiraGen began using AcademicLabs as their affordable cockpit for scientific intelligence. Even with just a “first dive,” the impact was clear:
For KiraGen, AcademicLabs transformed scientific landscaping from a bottleneck into a driver of progress:
As Ryan Murray summarized:
“AcademicLabs has been really useful for us - from helping realign our grant applications to giving us a clear view of new indications we otherwise wouldn’t have touched.
For a small biotech without a dedicated intelligence team, it’s a powerful tool.”
Confo Therapeutics identifies scientific experts seamlessly using AcademicLabs.
Confo Therapeutics identifies scientific experts seamlessly using AcademicLabs, eliminating a time sink in their drug discovery pipeline and allowing their work to move forward with a newfound confidence.
BioRN optimizes its scouting services with AcademicLabs.
Read the full story how this collaboration bolstered BioRN's scouting capabilities, ensuring they remained at the forefront of connecting academia and industry.
